Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|August 4, 2021
Immune-checkpoint inhibitors in pituitary malignanciesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation statusAlba A Brandes, Alicia Tosoni, Enrico Franceschi, et al.
Cancers|August 12, 2022
Adult Medulloblastoma: Updates on Current Management and Future PerspectivesEnrico Franceschi, Caterina Giannini, Julia Furtner, et al.
BMC Cancer|February 20, 2010
Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceLuca Morandi, Enrico Franceschi, Dario de Biase, et al.
Advances in Therapy|December 2, 2021
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-AnalysisVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cells|January 11, 2024
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, et al.
Cancer|April 22, 2005
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinibAntonio M P Omuro, Mark G Kris, Vincent A Miller, et al.
Biomedicines|December 23, 2022
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-OncologyLidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Immunotherapy|January 21, 2021
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastasesVincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic TargetsIlaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|August 4, 2021
Immune-checkpoint inhibitors in pituitary malignanciesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation statusAlba A Brandes, Alicia Tosoni, Enrico Franceschi, et al.
Cancers|August 12, 2022
Adult Medulloblastoma: Updates on Current Management and Future PerspectivesEnrico Franceschi, Caterina Giannini, Julia Furtner, et al.
BMC Cancer|February 20, 2010
Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceLuca Morandi, Enrico Franceschi, Dario de Biase, et al.
Advances in Therapy|December 2, 2021
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-AnalysisVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cells|January 11, 2024
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, et al.
Cancer|April 22, 2005
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinibAntonio M P Omuro, Mark G Kris, Vincent A Miller, et al.
Biomedicines|December 23, 2022
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-OncologyLidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Immunotherapy|January 21, 2021
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastasesVincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic TargetsIlaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, et al.
Pageof 17